 |
PDBsum entry 2fo5
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
2fo5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Heterologous expression, Purification, Refolding, And structural-Functional characterization of ep-B2, A self-Activating barley cysteine endoprotease.
|
 |
|
Authors
|
 |
M.T.Bethune,
P.Strop,
Y.Tang,
L.M.Sollid,
C.Khosla.
|
 |
|
Ref.
|
 |
Chem Biol, 2006,
13,
637-647.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
We describe the heterologous expression in Escherichia coli of the proenzyme
precursor to EP-B2, a cysteine endoprotease from germinating barley seeds. High
yields (50 mg/l) of recombinant proEP-B2 were obtained from E. coli inclusion
bodies in shake flask cultures following purification and refolding. The zymogen
was rapidly autoactivated to its mature form under acidic conditions at a rate
independent of proEP-B2 concentration, suggesting a cis mechanism of
autoactivation. Mature EP-B2 was stable and active over a wide pH range and
efficiently hydrolyzed a recombinant wheat gluten protein, alpha2-gliadin, at
sequences with known immunotoxicity in celiac sprue patients. The X-ray crystal
structure of mature EP-B2 bound to leupeptin was solved to 2.2 A resolution and
provided atomic insights into the observed subsite specificity of the
endoprotease. Our findings suggest that orally administered proEP-B2 may be
especially well suited for treatment of celiac sprue.
|
 |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Crystal Structure of Mature EP-B2 Complexed with
Leupeptin
|
 |
Figure 6.
Figure 6. Activity of EP-B2 against the Proteolytically
Resistant 33-mer Peptide from α2-Gliadin
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Cell Press:
Chem Biol
(2006,
13,
637-647)
copyright 2006.
|
 |
|
|
|
|
 |